Author
Listed:
- Avishai Gavish
(Weizmann Institute of Science)
- Michael Tyler
(Weizmann Institute of Science)
- Alissa C. Greenwald
(Weizmann Institute of Science)
- Rouven Hoefflin
(Weizmann Institute of Science
Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg)
- Dor Simkin
(Weizmann Institute of Science)
- Roi Tschernichovsky
(Weizmann Institute of Science
Rabin Medical Center)
- Noam Galili Darnell
(Weizmann Institute of Science)
- Einav Somech
(Weizmann Institute of Science)
- Chaya Barbolin
(Weizmann Institute of Science)
- Tomer Antman
(Weizmann Institute of Science)
- Daniel Kovarsky
(Weizmann Institute of Science)
- Thomas Barrett
(Washington University School of Medicine
Washington University School of Medicine)
- L. Nicolas Gonzalez Castro
(Massachusetts General Hospital and Harvard Medical School
Broad Institute of MIT and Harvard
Dana-Farber Cancer Institute
Brigham and Women’s Hospital)
- Debdatta Halder
(Weizmann Institute of Science)
- Rony Chanoch-Myers
(Weizmann Institute of Science)
- Julie Laffy
(Weizmann Institute of Science)
- Michael Mints
(Weizmann Institute of Science
Karolinska Institute)
- Adi Wider
(Weizmann Institute of Science)
- Rotem Tal
(Weizmann Institute of Science)
- Avishay Spitzer
(Weizmann Institute of Science)
- Toshiro Hara
(Massachusetts General Hospital and Harvard Medical School
Broad Institute of MIT and Harvard)
- Maria Raitses-Gurevich
(The Oncology Institute, Chaim Sheba Medical Center)
- Chani Stossel
(The Oncology Institute, Chaim Sheba Medical Center
Tel Aviv University)
- Talia Golan
(The Oncology Institute, Chaim Sheba Medical Center
Tel Aviv University)
- Amit Tirosh
(Tel Aviv University
Chaim Sheba Medical Center)
- Mario L. Suvà
(Massachusetts General Hospital and Harvard Medical School
Broad Institute of MIT and Harvard)
- Sidharth V. Puram
(Washington University School of Medicine
Washington University School of Medicine)
- Itay Tirosh
(Weizmann Institute of Science)
Abstract
Each tumour contains diverse cellular states that underlie intratumour heterogeneity (ITH), a central challenge of cancer therapeutics1. Dozens of recent studies have begun to describe ITH by single-cell RNA sequencing, but each study typically profiled only a small number of tumours and provided a narrow view of transcriptional ITH2. Here we curate, annotate and integrate the data from 77 different studies to reveal the patterns of transcriptional ITH across 1,163 tumour samples covering 24 tumour types. Among the malignant cells, we identify 41 consensus meta-programs, each consisting of dozens of genes that are coordinately upregulated in subpopulations of cells within many tumours. The meta-programs cover diverse cellular processes including both generic (for example, cell cycle and stress) and lineage-specific patterns that we map into 11 hallmarks of transcriptional ITH. Most meta-programs of carcinoma cells are similar to those identified in non-malignant epithelial cells, suggesting that a large fraction of malignant ITH programs are variable even before oncogenesis, reflecting the biology of their cell of origin. We further extended the meta-program analysis to six common non-malignant cell types and utilize these to map cell–cell interactions within the tumour microenvironment. In summary, we have assembled a comprehensive pan-cancer single-cell RNA-sequencing dataset, which is available through the Curated Cancer Cell Atlas website, and leveraged this dataset to carry out a systematic characterization of transcriptional ITH.
Suggested Citation
Avishai Gavish & Michael Tyler & Alissa C. Greenwald & Rouven Hoefflin & Dor Simkin & Roi Tschernichovsky & Noam Galili Darnell & Einav Somech & Chaya Barbolin & Tomer Antman & Daniel Kovarsky & Thoma, 2023.
"Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours,"
Nature, Nature, vol. 618(7965), pages 598-606, June.
Handle:
RePEc:nat:nature:v:618:y:2023:i:7965:d:10.1038_s41586-023-06130-4
DOI: 10.1038/s41586-023-06130-4
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- F. Nadalin & M. J. Marzi & M. Pirra Piscazzi & P. Fuentes-Bravo & S. Procaccia & M. Climent & P. Bonetti & C. Rubolino & B. Giuliani & I. Papatheodorou & J. C. Marioni & F. Nicassio, 2024.
"Multi-omic lineage tracing predicts the transcriptional, epigenetic and genetic determinants of cancer evolution,"
Nature Communications, Nature, vol. 15(1), pages 1-23, December.
- Aleksandr Ianevski & Kristen Nader & Kyriaki Driva & Wojciech Senkowski & Daria Bulanova & Lidia Moyano-Galceran & Tanja Ruokoranta & Heikki Kuusanmäki & Nemo Ikonen & Philipp Sergeev & Markus Vähä-Ko, 2024.
"Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones,"
Nature Communications, Nature, vol. 15(1), pages 1-16, December.
- Junho Kang & Jun Hyeong Lee & Hongui Cha & Jinhyeon An & Joonha Kwon & Seongwoo Lee & Seongryong Kim & Mert Yakup Baykan & So Yeon Kim & Dohyeon An & Ah-Young Kwon & Hee Jung An & Se-Hoon Lee & Jung K, 2024.
"Systematic dissection of tumor-normal single-cell ecosystems across a thousand tumors of 30 cancer types,"
Nature Communications, Nature, vol. 15(1), pages 1-17, December.
- Anja Fischer & Thomas K. Albert & Natalia Moreno & Marta Interlandi & Jana Mormann & Selina Glaser & Paurnima Patil & Flavia W. Faria & Mathis Richter & Archana Verma & Sebastian T. Balbach & Rabea Wa, 2024.
"Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas,"
Nature Communications, Nature, vol. 15(1), pages 1-18, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:618:y:2023:i:7965:d:10.1038_s41586-023-06130-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.